Log in
Enquire now
‌

US Patent 7423153 Crystalline forms of gatifloxacin

Patent 7423153 was granted and assigned to Teva Pharmaceutical Industries on September, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
74231530
Patent Inventor Names
Ehud Amir0
Valerie Niddam-Hildesheim0
Shlomit Wizel0
Greta Sterimbaum0
Date of Patent
September 9, 2008
0
Patent Application Number
104367360
Date Filed
May 12, 2003
0
Patent Primary Examiner
‌
James O. Wilson
0
Patent abstract

Provided are novel crystalline forms of gatifloxacin denominated forms A, B, C, D, E1, F, G, H, I, and J, and methods for their preparation. Also provided are methods for making known crystalline forms of gatifloxacin, in particular forms omega and T2RP.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7423153 Crystalline forms of gatifloxacin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.